1. Impairment Testing Conducted
- Yes ☒ No □
2. Assessment Report Obtained for Financial Reporting Purposes
- Yes ☒ No □
| Asset Group Name | Assessment Agency | Assessor | Assessment Report Number | Assessment Value Type | Assessment Result |
|---|---|---|---|---|---|
| Green Cross (China) Biological Products Co., Ltd. and Subsidiary Stations | Beijing Zhongqi Hua Asset Appraisal Co., Ltd. | Song Feiyun, Wang Congshan | Zhongqi Hua Appraisal Report No. (2026) 8101 | Recoverable Amount | No Impairment |
| Anhui Glink Pharmaceutical Sales Co., Ltd. | Beijing Zhongqi Hua Asset Appraisal Co., Ltd. | Song Feiyun, Wang Congshan | Zhongqi Hua Appraisal Report No. (2026) 8100 | Recoverable Amount | Impairment of 110,465,396.54 RMB |
3. Existence of Impairment Indicators
| Asset Group Name | Existence of Impairment Indicators | Remarks | Impairment Provision | Remarks | Impairment Basis | Remarks |
|---|---|---|---|---|---|---|
| Green Cross (China) Biological Products Co., Ltd. and Subsidiary Stations | No | No | No Impairment | Not Applicable | ||
| Anhui Glink Pharmaceutical Sales Co., Ltd. | Yes | Market performance below expectations at acquisition | Yes | Special Assessment Report |
4. Goodwill Allocation
| Asset Group Name | Composition of Asset Group or Combination | Determination Method | Carrying Amount | Goodwill Allocation Method | Allocated Goodwill Original Value |
|---|---|---|---|---|---|
| Green Cross (China) Biological Products Co., Ltd. and Subsidiary Stations | Subsidiaries acquired at the time of goodwill formation | Single Asset Group | 363,258,756.31 | Based on major cash inflows independent of other assets | 612,721,939.02 |
| Anhui Glink Pharmaceutical Sales Co., Ltd. | Subsidiaries acquired at the time of goodwill formation | Single Asset Group | 115,027,420.42 | Based on major cash inflows independent of other assets | 115,274,088.67 |